Back to search

Article

Ancestry-associated immune signalling differences in atopic dermatitis and dupilumab treatment

2025-12-09

Abstract excerpt

<h4>Background</h4> Atopic dermatitis (AD) is a common atopic disease worldwide and dupilumab, a monoclonal antibody directing to the IL4/IL13 signalling, is emerging as an effective therapy for AD. Recently, there is report describing differences in AD severity and treatment responses to dupilumab among different geographic regions, but the underlying mechanisms remain unresolved. Patients’ ancestral backgrounds...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
588021d9-85fc-5f1b-82f4-09e64f0f7edd
DOI
10.64898/2025.12.08.25341816
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ancestry-associated immune signalling differences in atopic dermatitis and dupilumab treatmentDOI 10.64898/2025.12.08.25341816
Select a neighboring publication to make it the new centre.